(Q39956368)

15 September 2017

title

Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway (English)

1 reference

15 September 2017

0 references

1 reference

1 reference

Y Katsuno

1

1 reference

15 September 2017

A Hanyu

2

1 reference

15 September 2017

H Kanda

3

1 reference

15 September 2017

Y Ishikawa

4

1 reference

15 September 2017

F Akiyama

5

1 reference

15 September 2017

T Iwase

6

1 reference

15 September 2017

E Ogata

7

1 reference

15 September 2017

S Ehata

8

1 reference

15 September 2017

K Miyazono

9

1 reference

15 September 2017

T Imamura

10

1 reference

15 September 2017

language of work or name

English

0 references

publication date

28 July 2008

1 reference

15 September 2017

1 reference

15 September 2017

volume

27

1 reference

15 September 2017

issue

49

1 reference

15 September 2017

page(s)

6322-6333

1 reference

describes a project that uses

15 September 2017

MDA-MB-231-5a-D

0 references

MDA-MB-231-5a-D-TbetaFluc/Rluc

0 references

exact match

https://scigraph.springernature.com/pub.10.1038/onc.2008.232

0 references

cites work

Visualizing the dynamics of EGFR activity and antiglioma therapies in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Effect of Smad7 expression on metastasis of mouse mammary carcinoma JygMC(A) cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Bone morphogenetic protein signaling suppresses tumorigenesis at gastric epithelial transition zones in mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

TGF-beta signaling in tumor suppression and cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Ki26894, a novel transforming growth factor-beta type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Mixed metastatic lung cancer lesions in bone are inhibited by noggin overexpression and Rank:Fc administration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Specificity and versatility in tgf-beta signaling through Smads

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Proinvasive activity of BMP-7 through SMAD4/src-independent and ERK/Rac/JNK-dependent signaling pathways in colon cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

De novo crypt formation and juvenile polyposis on BMP inhibition in mouse intestine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Expression of bone morphogenetic protein in human adenocarcinoma cell line

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

The transforming activity of Ski and SnoN is dependent on their ability to repress the activity of Smad proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

TGF-beta signalling from cell membrane to nucleus through SMAD proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor-positive breast cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Bone morphogenetic proteins in development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Transforming growth factor-beta stimulates parathyroid hormone-related protein and osteolytic metastases via Smad and mitogen-activated protein kinase signaling pathways

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

A multigenic program mediating breast cancer metastasis to bone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Two major Smad pathways in TGF-beta superfamily signalling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Bone morphogenetic proteins inhibit the tumorigenic potential of human brain tumour-initiating cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Role of morphogenetic proteins in skeletal tissue engineering and regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Mechanisms of TGF-beta signaling from cell membrane to the nucleus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Controlling cell fate by bone morphogenetic protein receptors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

TGF-beta signaling: positive and negative effects on tumorigenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Diverse biological effect and Smad signaling of bone morphogenetic protein 7 in prostate tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2008.232

31 March 2020

Identifiers

DOI

10.1038/ONC.2008.232

1 reference

Dimensions Publication ID

15 September 2017

1052792067

0 references

1 reference